Back to results
US 8,524,665 B2Granted
Use of secretin in treatments of disorders associated with the amygdala
AssigneeThe McLean Hospital Corporation
InventorsDeborah A. Yurgelun-Todd, Perry F. Renshaw
Life of this patent
Estimating the term…
Abstract
In general, the present invention provides methods for treating disorders associated with the amygdala. The methods of treatment are based on the administration of a therapeutically effective amount of secretin to an individual suffering from a disorder associated with the amygdala, e.g., bipolar disorder or a substance use disorder.
Claims5
A method for ameliorating bipolar disorder in an individual in need thereof, said method comprising administering an amount of secretin sufficient to ameliorate bipolar disorder in said to individual.
Dependencies are inferred from the claim text.